Drug Testing

News, Articles, Videos and other content about Drug Testing

Issues Break Through Breed Barriers for TRA, HTA

The first joint meeting of the boards of the Thoroughbred Racing Associations and Harness Tracks of America was considered a success, but whether the two organizations continue to meet jointly on a regular basis remains to be seen.

Shock-Wave Regulations, Threshold Levels Sought

Kentucky officials will consider regulations for use of shock-wave therapy in racehorses and also whether money for equine drug research should be spent on establishing threshold levels and withdrawal times for permitted medications.

Report: EPO Antibodies Found in Texas Horses

  • News

Antibodies for erythropoeitin, a blood-doping substance commonly known as EPO, were found in six racehorses at Sam Houston Race Park, the Dallas Morning News reported Feb. 18.

Drug Consortium Elects Officers; Progress on Policy

The Racing Medication and Testing Consortium has elected officers, chosen an executive director, and put the finishing touches on few sections of its proposed model policy for medication and drug testing. Breeders' Cup president D.G. Van Clief Jr. was elected chairman.

Kentucky OKs Study of Out-of-Competition Testing

The Kentucky Racing Commission has decided to form a committee to explore the testing of horses on days they're not scheduled to race. The decision stems from an earlier classification of erythropoeitin and the process of blood-doping as a prohibited practice.

Texas Renews Equine Drug-Testing Contract

  • News

The Texas Racing Commission has renewed its drug-testing contract with Texas Veterinary Medical Diagnostic Laboratory, and also approved some changes in the racing schedule at Manor Downs for 2003.

Medication Consortium Incorporates, Broadens Scope

The Racehorse Medication and Testing Consortium formed earlier this year has incorporated as a charitable organization and issued its goals and objectives, one of which has been broadened to include the auction and training aspects of the Thoroughbred business.

National HBPA to Issue Revised Medication Proposal

The National Horsemen's Benevolent and Protective Association is prepared to release a revised proposal for a national policy on drug testing and therapeutic medication. The document deals with Class 1, 2, 3, and 4 medications, as well as prohibited practices.

Chairman Hopes Kentucky is Medication Model

The chairman of the Kentucky Racing Commission said Sept. 13 he hopes a revised race-day medication policy for the Bluegrass state becomes a model for the rest of the country as it pushes toward uniformity in racehorse medication and drug testing.

Kentucky Proposal: Only Five Race-Day Medications

Horsemen, veterinarians, racing officials, and regulators in Kentucky have been working behind the scenes to develop a new medication policy for the state that figures to greatly influence the debate over a uniform medication policy for the United States.

Florida Morphine Case Raises Zero-Tolerance Question

The Florida Division of Pari-Mutuel Wagering in August filed an administrative complaint against trainer Henry Collazo, alleging that a horse he ran at Calder Race Course tested positive for a derivative of morphine. The case has again put Florida's zero-tolerance policy under scrutiny.

Super Tests: Calls for Therapeutics Not Unexpected

In the second round of "super tests" performed under the guidance of the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force, there were no new positives for Class 1, 2, and 3 medications, according to a final report recently released. There were, however, 454 confirmations for therapeutic drugs.

Commission to Rule on Appeal of Prozac Suspension

  • News

The Kentucky Racing Commission on June 25 will rule on an appeal of a 150-day suspension by trainer William Deaton concerning a positive test for Prozac in one of his horses at the Turfway Park meet earlier this year.

Stirling, Arthur Named to NTRA Drug Testing Committee

Kent Stirling, executive director of the Florida Horsemen's Benevolent and Protective Association, and Dr. Rick Arthur, a vice president of Oak Tree Racing Association, have been named to the National Thoroughbred Racing Association's Racing Integrity and Drug Testing Task Force.

CHRB Fines Two Trainers for Del Mar Positives

Trainers Ben Cecil and Howard Zucker were slapped with fines by the California Horse Racing Board for positive drug tests produced from races at Del Mar last summer, it was announced May 30.

Race-Day Medications: The Debate Goes On

As the Racing Medication and Testing Consortium continues its march toward uniformity in Thoroughbred racing, battle lines are being formed by other groups that believe a furosemide-only policy on race days is too extreme.

Medication Group's Next Meeting in Kentucky

  • News

Representatives of 15 Thoroughbred, Quarter Horse, and Standardbred organizations will meet May 1 at a by-invitation-only meeting to implementation of recommendations on drug-testing, medication, security, and enforcement.

Medication, Regulatory Matters on Front Burner

While the Thoroughbred industry makes an aggressive push toward unification on the issue of drug testing and medication, two organizations involved in the regulation of racing -- the Association of Racing Commissioners International and the National Association of Pari-Mutuel Regulators -- continue to go their separate ways.

Is Medication Really the Root of Racing's Problems?

Uniformity in equine drug-testing and medication use won't come easy if comments made by panelists at the University of Florida's Equine Medical Symposium are any indication. If anything, the March 15 discussion revealed splits within the racing industry and brought up the question as to whether medication is really the root of the industry's problems.

Therapeutic Medications in Spotlight Once Again

As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared to release the results of round two of its super-testing program, the University of Florida appropriately kicked off its first Equine Medical Symposium March 14 with discussion on some therapeutic medications.

Gallagher Leaves NTRA for NYRA Position

  • News

Jim Gallagher, executive director of the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force, will leave the organization March 28 to take the position of vice president of pari-mutuel operations for the New York Racing Association.

Kentucky HBPA Polling Horsemen on Drug Policies

The Kentucky Horsemen's Benevolent and Protective Association is polling horsemen to get their opinions on the state's medication policies, which include a ban on all Class 1, 2, and 3 drugs within 48 hours of a race, and use of anti-inflammatory anti-bleeding medications on race day.

Medication, Equine Health on Symposium Agenda

A panel discussion on medication use and regulations in the pari-mutuel industry will be part of an equine medical symposium hosted by the University of Florida College of Veterinary Medicine March 14-15 in Hollywood Beach, Fla.

Most Popular Stories